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Abstract
Background: Achyrocline bogotensis has been traditionally used to treat infections of skin, respiratory, tract urinary
and other infections, but not to treat viral gastrointestinal disease. In this study, this Colombian native medicinal
plant was investigated by its in vitro anti-rotavirus and anti-astrovirus activity.
Methods: Several extracts and fractions phytochemically obtained from A. bogotensis were evaluated initially for their cell
toxicity on MA104 and Caco2 cells and then for their anti-rotavirus (RRV) and anti-astrovirus (Yuc8) activity following three
strategies: pre-treatment of cells (blocking effect), direct viral activity (virucidal effect) and post-treatment of infected cells
(reduction of viral yield post-infection). In addition qualitative chemical studies were developed for the active compounds.
Results: Non-toxic concentrations of a fraction obtained exhibited antiviral activity against both viruses characterized by a
virucidal effect and by the reduction of the infectious particles produced post-infection. Steroids, sterols, terpenes,
phenols, flavonoids and sesquiterpenlactones were identified qualitatively in the active fraction.
Conclusions: A. bogotensis contains substances with in vitro antiviral activity against rotavirus and astrovirus. This study
confirms their anti-microbial properties and describes by the first time its antiviral activity in vitro.
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Background
Achyrocline bogotensis (Kunth) DC. (Compositae) is an
endemic plant of Colombia known with the vernacular
names vira vira, cenizo and suso. This species is trad-
itionally used in decoction to treat skin diseases, chronic
cough and as expectorant, and in infusion to treat pros-
tatitis, kidney pain, inflammatory processes and to clean
the urinary tract [1]. Additionally, anti-cancer activity of
flavonoids obtained from A. bogotensis was reported in
vitro on several cell lines [2]. Its in vitro activity against
bacteria and fungi has been described [1], but there are
no reports on antidiarrheal properties or antiviral activ-
ity of substances extracted from this medicinal plant.
Rotavirus belongs to the family Reoviridae, which in-
cludes naked icosahedral viruses with three concentric
shells of approximately 70 nm in diameter and double-
stranded ribonucleic acid (dsRNA) divided into 11 gene
segments that encode five non-structural and six struc-
tural proteins. Rotavirus infects a wide variety of mam-
mals included humans. It is the most common cause of
severe gastroenteritis in infants and young children
worldwide, who acquire the virions by direct fecal-oral
route or by fecally contaminated food and water, and
respiratory droplets [3, 4].
Astrovirus (AstVs) belongs to the family Astroviridae and
infects mammals (Mamastrovirus) and birds (Avastrovirus)
[5–8]. Astroviral genome (ssRNA positive) is divided into
three open reading frames (ORF1a, ORF1b and ORF2)
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structural polyprotein, respectively [8]. This virus has
been associated mainly with gastroenteritis in mammals
and hepatitis and fatal nephritis in birds [9]; nevertheless,
since 2010 it has been associated with neurological disor-
ders in humans, minks and cows [10–12].
Diarrhea remains the second leading cause of death
among children under five globally [13]. Viruses are the
major etiological agents of acute gastroenteritis (AGE) in
this population. The most frequent enteropathogenic
viruses associated with AGE are rotavirus, norovirus,
enteric adenovirus, astrovirus and saporovirus [14], be-
ing all transmitted by the fecal-oral route. Rotavirus
alone causes annually two million hospitalizations and
500 deaths in developing countries [15]. Several reports
have described the prevalence of the rotavirus as the
single cause of diarrhea in children; however, it is well
known that this virus can also be found co-infecting
along with other viruses as astrovirus [16–18].
At present, the viral diarrhea treatment focuses on
fluid replacement with oral rehydration salts (ORS) to
prevent dehydration and zinc treatment to decrease its
severity and duration. So far, no specific antiviral drug is
available to treat the rotavirus infection [19]. In the case
of astrovirus, lack of understanding its pathogenesis has
delayed the search of effective antiviral substances.
The difficulty in developing new antiviral agents is a
significant challenge. Nowadays, there are several prob-
lems that must be overcome such as the limited avail-
ability of new synthetic molecules, the toxicity exerted
on the host and the resistance exhibited by new mutant
viruses. One alternative is the use of new compounds
that can be isolated from medicinal plants, which have
traditionally been used for centuries.
In order to shed light on a potential use of A. bogotensis
in controlling infections produced by enteropatho-
genic viruses as rotavirus and astrovirus, we evaluated
the in vitro antiviral activity of substances obtained
from this medicinal plant using three strategies. Low
non-toxic concentrations of a fraction phytochemically
obtained showed a significant virucidal effect and a
reduction of the number of infectious particles produced




Five kg of aerial material (leaves and stems) from adult
plants were collected for the purposes of this study and
for verifying the taxonomic identification by botanist
Henry Yesid Bernal of the herbarium of the Pontificia
Universidad Javeriana (HPUJ) - Bogotá, Colombia. Voucher
specimens were deposited at HPUJ. Plant material collected
for the study was taken to the Phytochemistry Laboratory
of the same university.
The collection and processing of wild material was cov-
ered by the collection permission number 1439 issued by
the National Environmental Licensing Authority – ANLA)
and the Contract No. 084 on genetic resource access
issued by the Ministry of Environment and Sustainable
Development of Colombia.
Liquid-liquid fractionation and screening of antiviral
compounds
The leaves and stems of A. bogotensis were initially dried
at room temperature (RT) and then washed using
chloroform and hexane prior the obtainment of E1 and
E2 extracts, respectively. Then, the washed leaves and
stems were cold soaked with ethanol to obtain the E3
extract. The E3 extract was fractioned by continuous
liquid/liquid fractionation with hexane, dichloromethane
and ethyl acetate for obtaining the F1, F2 and F3 fractions,
respectively. All the extracts and fractions were placed in
a rotary evaporator at 40 °C to concentrate the substances.
For further testing of biological activity, the extracts
and the fractions were dissolved in dimethyl sulfoxide
(DMSO, Merck/Cat. # 317275) to a final concentration
of 100 mg/ml (stock solution). Serial dilutions 1:2 were
prepared ranging from 1.000 μg/ml down to 0 μg/ml for
each extract and fraction in Advanced DMEM (Dulbecco’s
Modified Eagle Medium Gibco®/Cat # 12491-023) supple-
mented with 2 mM L-glutamine and antibiotic/antimycotic,
without fetal bovine serum (FBS).
Cell lines
MA104 and Caco2 cells were cultured in Advanced
DMEM supplemented with 4 and 5 % Fetal Bovine Serum
(FBS) respectively, 2 mM L-glutamine and antimicotic/
antibiotic in a 5 % CO2 atmosphere at 37 °C.
Cell toxicity assays
Ten thousand MA104 and fifteen thousand Caco2 cells
were seeded in separate wells in 96 multiwell plates and
were cultured for 24 and 72 h respectively, as mentioned
above. At this time, the medium was removed, the cells
washed once with Phosphate Buffer Saline (PBS), and
100 μL of several dilutions 1:2 (from 1.000 μg/mL to
0 μg/mL) of each extract and fraction (solubilized previ-
ously in DMSO at a final concentration of 100 mg/mL)
diluted in Advanced DMEM without FBS. Each resulting
mixture was applied to MA104 and Caco2 cells by tripli-
cate for 96 h. After this time, cell viability was evaluated
using firstly trypan blue exclusion assay by removing the
culture medium and adding 50 μL per well of trypan
blue (0.4 % in sterile PBS pH = 7.2). Then, three random
fields per well were observed and each one recorded
photographically. Secondly, the MTT (3-(4,5-dimetiltiazol-
2-il)-2,5-difeniltetrazolio – Sigma-Aldrich®/Cat# M5655)
method was followed according to the manufacturer’s
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instructions. Optic densities were measured at 492 nm in
a Multiskan Reader MCC/340 Labsystems. Additionally,
in order to know the toxic effect of the solvent used, sev-
eral concentrations of DMSO (0, 0.5, 1, 1.5, 2, 2.5, 3.0, 3.5,
4.0, 4.5 and 5 %) were also evaluated in the same way. All
assays were done three times independently by triplicate.
Viruses and antibodies
Rhesus rotavirus (RRV strain) and human astrovirus
serotype 8 (HAstV-8 Yuc8 strain) were multiplied in
MA104 or Caco2 cells, previously cultured as mentioned
above. For this, 10 and 200 μg/ml porcine pancreatic
trypsin (Sigma-Aldrich®/Cat# T-4799) were added to
RRV and Yuc8 respectively, during 1 h at 37 °C in order
to activate viral particles. After this time, soybean inhibi-
tor (Life Technologies®/Cat# R-007-100) was added for
5 min at RT. Then, the activated viruses were added (ad-
sorption period) to each cell line respectively, during 1 h
in a 5 % CO2 atmosphere at 37 °C. After one wash with
PBS, fresh culture medium without FBS was added to
complete 10 (RRV) and 12 (Yuc8) hour post-infection (hpi)
respectively, until the immunodetection test (See below).
Anti-TLP (Triple – Layered Particles) polyclonal anti-
bodies donated by Dr. Carlos Arturo Guerrero from
Universidad Nacional de Colombia or anti-Yuc8 poly-
clonal antibodies donated by Dr. Ernesto Méndez† from
Instituto de Biotecnología – Universidad Nacional
Autónoma de México were used to detect cytoplasmic
viral antigens by immunocytochemistry or flow cytometry.
The conjugates and substrates used were peroxidase –
goat anti-rabbit IgG (Invitrogen™/Cat# 65-6120), AEC (3-
Amino-9-ethylcarbazole – Sigma-Aldrich®/Cat# A5754)
with hydrogen peroxide 0.02 %, and Alexa Fluor® 488 Goat
(Life Technologies/Cat# A11034), respectively.
Anti-rotavirus and anti-astrovirus activity assays
In order to determine if the extracts and fractions ob-
tained can exert an anti-rotavirus and anti-astrovirus
activity, three strategies were evaluated based on a
blocking effect, a virucidal effect or a reduction of infec-
tious particles produced post-infection (viral yield). In
addition, to develop these strategies a bio-guided assay
was carried out according to the results of each strategy.
Blocking effect assay
MA104 or Caco2 cells previously cultured in 96 multi
well plates as mentioned before were covered for 24 h at
37 °C in a 5 % CO2 atmosphere with several non-toxic
concentrations of each of the extracts or fractions di-
luted in culture media without FBS. Then substances
were removed and the cells washed two times with PBS
and challenged with rotavirus – RRV strain – or astro-
virus – Yuc8 strain – at a multiplicity of infection (MOI)
of 1, previously activated with 10 μg/mL or 200 μg/mL
of trypsin respectively, at 37 °C for 1 h. After this viral
adsorption period, the inoculum was removed, the cells
washed once with PBS, and fresh culture media without
SFB was added to complete 10 (RRV) or 12 (Yuc8) hpi
before cells were processed by immunocytochemistry
(See below). DMSO and infected or uninfected cells
(MOCK) were included as controls of the activity and
viral infectivity. All experiments were carried out three
times independently by triplicated.
Virucidal effect assay
The same concentrations evaluated in the above experi-
ments from each extract and fraction were co-incubated
with the previously trypsin activated rotavirus or astro-
virus at a final MOI of 5 (RRV) or 1 (Yuc8) for 1, 2 and
4 h at 37 °C in a 5 % CO2 atmosphere. Then, each of the
mixtures was placed on MA104 or Caco2 cells for 1 h at
37 °C in a 5 % CO2 atmosphere. The inoculum was re-
moved, the cells washed once with PBS, and fresh cul-
ture medium without SFB was added to complete 10
(RRV) or 12 (Yuc8) hpi, before being processed by im-
munocytochemistry. Viruses without treatment and vi-
ruses with DMSO were included as controls of the
activity and viral infectivity. All experiments were car-
ried out three times by triplicated.
Viral yield reduction assay
MA104 and Caco2 cells were cultured in 96 multi-well
plates as mentioned before. Then, each cell line was
infected with rotavirus and astrovirus at MOI of 1, pre-
vious viral activation with trypsin for 1 h. After the
adsorption period, the inoculum was removed, the cells
washed once with PBS and the same concentrations of
each extract and fractions diluted in culture media with-
out SFB were added to complete 24 h at 37 °C in a 5 %
CO2 atmosphere. At this time the viruses were harvested
by freezing and thawing twice, centrifuged at 16,000 × g
for 1 min and the supernatant recovered. The focus
forming units per milliliter (FFU/mL) of rotavirus and
astrovirus present in the viral suspension were then
quantified by immunocytochemistry. Infected or mock
infected cells without treatment were included as con-
trols of the assay. Quantifications were performed three
times independently by triplicated.
Determination of the antiviral activity
Immunocytochemistry
MA104 and Caco2 cells were cultured in 96 multi-well
plates as mentioned above. After 10 or 12 hpi with RRV
or Yuc8 respectively, the culture medium was removed
and 80 % acetone in PBS was added for 15 min at RT.
Two washes with PBS were performed and 50 μl of anti-
TLPs 1:3000 or anti-Yuc8 1:5000 respectively, were
added per well and incubated for 1.5 h at 37 °C in moist
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chamber. After three washes with PBS, 50 μl of the
conjugate was added for 1 h at 37 °C in moist chamber.
Finally, the conjugate was removed, cells were washed
three times, and AEC (3-Amino-9-ethylcarbazole) with
0.02 % hydrogen peroxide was added to verify cytoplas-
mic brown staining. The reaction was stopped with two
water washes and the focus forming units per milliliter
(FFU/mL) were quantified and photographic records of
three random fields per well were obtained with an
Olympus CKX41 inverted microscope.
Flow cytometry assay
Virucidal activity was quantified using flow cytometry in
a Becton Dickinson FACSAria II. After the treatments of
cells or viruses at a MOI of 5 (RRV) or 2 (Yuc8), cells
were detached and fixed with 2 % paraformaldehyde for
15 min at RT. After two washes with PBS, the cells were
permeabilized with 0.03 % Triton X-100 for 15 min at
RT and anti-TLPs or anti-Yuc8 polyclonal antibodies
prepared in PBS containing 0.03 % Triton X-100 and
5 % FBS were added for 1.5 h at RT. After this time, two
washes were done and Alexa Fluor 488® was added in
the dark for 1.5 h at RT. Finally, three washes were done
and the percentages of infected cells were obtained.
These assays were performed three times independently
by duplicate.
Preliminary phytochemical characterization of antiviral
substances
In order to make an approximation to the composition
of the extracts or fractions with antiviral activity in this
study, we carried out the following qualitative chemical
tests: Liebermann-Burchard, ammonium molybdate, ferric
chloride, Dragendorff reagent, Bornträger, Shinoda,
Salkowski, Baljet, Molisch and foam index.
Statistical analysis
Analysis of variance (ANOVA) for repeated measures
and univariate analysis were applied using the SPSS
software version 21 (SPSS Inc., Chicago, IL). The sig-
nificance for these analyses was P < 0.05.
Results
Cytotoxicity exerted by the extracts and fractions
obtained on MA104 and Caco2 cells
Several concentrations of three extracts and three frac-
tions phytochemically obtained were tested by their toxic
effect on MA104 and Caco2 cells by trypan blue exclu-
sion assay and MTT assay for 96 h. The results obtained
with both tests were consistent, because those concen-
trations that allowed obtaining high cell viability per-
centages by the MTT method, also showed kept the cell
membrane structure using trypan blue stain. Figure 1
shows the viability percentages obtained with the MTT
method on MA104 (Fig. 1a) and Caco2 (Fig. 1b) cells. In
general, the most cytotoxic substances were found in the
extracts E1, E2 and the fraction F1. The maximum non-
toxic concentrations for each extract and fraction were
determined and defined as those concentrations which
allowed viabilities greater than 95 %. In addition, the
toxicity exerted by the DMSO (Fig. 1c) showed that con-
centrations lower than 0.5 % allowed a viability greater
than 96 % in both cell lines during 96 h, while concen-
trations greater than 0.5 % exerted differential toxic ef-
fects; concentrations higher than 1 % were considerably
more toxic on MA104 cells than on Caco2 cells.
The fraction F1 from A. bogotensis at non-cytotoxic
concentrations exerts an anti-rotavirus and anti-astrovirus
activity
The antiviral activity exerted by different non-toxic con-
centrations of the extracts and fractions obtained from
A. bogotensis in the study against rotavirus and astro-
virus was evaluated considering (1) a possible blocking
of viral receptors, (2) a virucidal activity, or (3) a de-
crease in the production of infectious viral particles after
the replicative cycle. Each experiment included an activ-
ity control using the solvent of the substances evaluated
(DMSO) present in each extract or fraction. For the first
strategy, several dilutions 1:2 of all extracts and fractions
from the maximum non-toxic concentrations previously
determined were placed on the cells for 24 h prior rota-
virus or astrovirus infection. The results showed no
blocking effect of the viral infection (Data not shown) by
immunocytochemistry test. Then, the same dilutions of
the substances were co-incubated with infectious parti-
cles of rotavirus (MOI of 5) – RRV strain – or human
astrovirus serotype 8 (MOI of 2) – Yuc8 strain, previ-
ously activated with trypsin. Only the fraction F1 showed
a virucidal effect on RRV and Yuc8. Figure 2 shows the
effect observed initially by immunocytochemistry with
RRV (Fig. 2a) and Yuc8 (Fig. 2b) co-incubated during
one hour with F1 fraction on MA104 and CaCo2 cells,
respectively. Simultaneously and unexpectedly, it was
found that the low DMSO concentrations (≤0.016 %)
present in the different dilutions of the tested fraction
exhibited a similar effect on the two viruses, with a
greater activity against RRV.
In order to confirm and quantify the virucidal effect
exerted by F1 and DMSO, flow cytometry was developed
from the co-incubation during 1, 2 and 4 h of the frac-
tion with RRV (MOI of 5) and Yuc8 (MOI of 2). The
results confirmed the virucidal effect of F1 with all
concentrations (0.98 to 15.6 μg/ml) and times tested;
additionally, 3.91 μg/ml was the concentration that ex-
hibited the greatest virucidal activity; thus, this concen-
tration of F1 co-incubated for 1, 2 and 4 h with RRV
reduced the viral infectivity by 33.6, 30.5 and 41.8 %,
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Fig. 1 Viability of MA104 (a) and CaCo2 (b) cells in the presence of extracts, fractions and DMSO (c) measured by the MTT (DO492nm) method.
Table under the X axis (Figures a and b) corresponds to the percentage (%) of cell viability obtained
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respectively, while with Yuc8 reduced the infectivity by
33, 24.4 and 46 %, respectively. The statistical analysis of
this effect on RRV using analysis of variance (ANOVA)
for repeated measures with an error probability of 0.05
(p <0.05), revealed the existence of statistically significant
differences between the times tested (p = 0.039), con-
firming that prolonged exposure of RRV particles to
the fraction F1, exerts a greater virucidal effect (Fig. 3a);
additionally, it was confirmed the significance of the
virucidal effect of F1 in comparison with DMSO on
Fig. 2 Evaluation of the virucidal effect exerted by F1 fraction from Achyrocline bogotensis (Kunth) DC. (Compositae) on (a) rotavirus (RRV strain/MOI = 5)
and (b) astrovirus (Yuc8 strain/MOI = 2). Viruses were first co-incubated with several nontoxic concentrations of F1 during 1 h at 37 °C, and
then mixtures were placed on Ma104 and Caco2 cells, respectively. At 10 or 12 hpi intracellular virions were immunodetected in order to find
a decrease of the infectivity. Viruses co-incubated with the corresponding concentrations of the solvent of F1 (DMSO), were used as controls.
The pictures were taken with a 10X objective in an Olympus CKX41 microscope
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RRV infectious particles (p = 0.000), which is time-
dependent.
Moreover, the statistical analysis of the virucidal effect
exerted by the F1 fraction co-incubated during 1, 2 and
4 h with Yuc8 (Fig. 3b) confirmed significant differences
between the times studied (p = 0.011). Furthermore,
the analysis also showed significant differences be-
tween the effect produced by the F1 fraction and the
DMSO (p = 0.000), being greater with F1, and it was
also revealed that the interactions of the variables expos-
ure time and concentration, and exposure time and sub-
stance (F1 or DMSO) have significant differences (p = 0.03
and p = 0.02 respectively), confirming that the effect of F1
on Yuc8 is dependent of the time and dose (Fig. 3c), and
in turn that the DMSO effect is significantly less.
Finally, the third strategy was to evaluate whether the
substances obtained exert post-infection antiviral activity
against rotavirus and astrovirus by reducing the infec-
tious viral yield. For this, infected cells (MOI of 1) were
treated with different concentrations of F1 fraction and
the FFU/ml of RRV and Yuc8 was quantified by im-
munocytochemistry. The results showed again that the
F1 fraction has antiviral activity against rotavirus and
astrovirus when it is added immediately after virus ad-
sorption. Figure 4 shows the statistical analysis of the
effect using univariate ANOVA with an error probability
of 0.05 (p <0.05) which showed significant differences
between the substances evaluated (Fraction F1 and
DMSO) on RRV and Yuc8 (p = 0.001 and p = 0.000, re-
spectively) confirming the significant decrease of the
viral infectious progeny by F1 on RRV infected cells
(Fig. 4a). By the contrary, no statistically significant ef-
fect on the infectious particle yield of Yuc8 was observed
with DMSO (Fig. 4b), but a significant reduction with F1
(p = 0000) was detected. The F1 concentrations assessed
showed no statistically significant differences.
Phytochemical partial characterization of F1 fraction
The qualitative chemical tests performed showed that
the fraction F1 contains steroids, sterols, terpenes, phe-
nols, flavonoids and sesquiterpenlactones.
Discussion
The vademecum of medicinal plants of Colombia [1] in-
cludes 127 species among which 40 are native and two
Fig. 3 Statistical analysis of the virucidal effect exerted by the F1
fraction on rotavirus (RRV strain/MOI = 5) (a) and astrovirus (Yuc8
strain/MOI = 2) (b, c) by flow cytometry. Viral particles were co-incubated
with F1 during 1, 2 and 4 h at 37 °C. The data represent the percentage
(%) of infected cells, the bars represent the standard error of the mean
(SEM) of three independent experiments by duplicated using
flow cytometry. p ≤ 0.05 (ANOVA with repeated measures - RM)
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are endemic. Particularly, Achyrocline bogotensis is one
of these endemic species which has been traditionally
used to treat prostatitis, kidney pains, inflammatory pro-
cesses and to clean the urinary tract [1, 20]. In Colombia
a phytopharmaceutical form is currently approved as co-
adjuvant in the treatment of mild inflammation of the
urinary tract. To date there are no reports of studies de-
signed to assess the antiviral activity of this medicinal
plant; however, other species of the same genus such as
A. satureioides and A. flaccida have been reported by their
antiviral activity against Human Herpes Virus [21–23],
Human Immunodeficiency Virus [24] and Western Equine
Encephalitis Virus [25].
In this study for the first time the anti-rotavirus and
anti-astrovirus activities exerted by extracts and fractions
obtained from A. bogotensis were investigated using three
in vitro strategies to make an approximation of their po-
tential use in vivo. Although an antiviral effect mediated
by the blocking of cellular receptor molecules involved in
the entry of RRV and Yuc8 was not found, a virucidal ef-
fect and a decrease of the viral yield were confirmed using
the F1 fraction. Nevertheless, other studies have shown
that natural compounds isolated from licorice root (Gly-
cyrrhiza glabra) have the ability to inhibit rotavirus infec-
tion in vitro used as a pre-treatment [26, 27]. However,
previous phytochemical studies carried out with A. bogo-
tensis demonstrated the presence of flavonoids [28] which
have been extensively studied by their antiviral properties,
including the inhibitory effect on rotavirus infection
[29, 30]. Qualitative tests carried out in this work aimed
to a partial characterization of the active F1 fraction
confirmed the presence of flavonoid compounds.
The main target organ of rotaviruses and astroviruses
is the small intestine, where their capsid proteins
undergo a trypsin-dependent cleavage to enhance the
entry to the mature enterocytes [9, 31]. The virucidal ac-
tivity of the F1 fraction demonstrated in this study has a
significant direct effect against the rotavirus (RRV) and
astrovirus (Yuc8) particles after a process of trypsiniza-
tion prior to the infection in vitro, suggesting that some
or all of the substances contained in this fraction have
the ability to bind unspecifically or to interact directly
with the structural viral proteins responsible for the
adhesion to the host cell, thus avoiding its infection. A
similar behavior was reported by Takahashi et al. in
2001, who identified a polysaccharide obtained from
another species of the family Asteraceae (Stevia
rebaudiana) with anti-rotavirus activity. This effect is
provided by the ability of the polysaccharide to adhere to
the VP7 glycoprotein, decreasing the adhesion of the virus
to the cells; further evidence suggests that the same effect
may be exerted on VP4 [32]. Another study reported
likewise the virucidal activity of extracts obtained from
Alpinia katsumadai (Zingiberaceae) when they were
co-incubated for one hour with porcine rotavirus (G5
P[7]) and bovine rotavirus (G8 P[7]) [33].
Similarly, the results of this study show that the F1
fraction exerted a significant virucidal activity against
the astrovirus (Yuc8 strain) depending on the exposure
time and fraction concentration. This is the first report
of substances of plant origin with virucidal activity
against astrovirus. Like rotavirus, astroviruses are naked
viruses that require prior trypsin-dependent cleavage to
enhance their infectivity [34]. Based on our results it is
possible to speculate that the interaction occurred
among substances contained in F1 is virus-nonspecific,
since it has been described that, for example, flavonoids
have the ability to bind to viral surface proteins and thus
prevent the infection [35].
Fig. 4 Statistical analysis of the anti-rotavirus (a) and anti-astrovirus
(b) activity exerted by the F1 fraction on the reduction of infectious
viral particles produced post-infection in vitro. The graphic shows the
focus forming units (FFU/ml) plus standard error of the mean (SEM)
from three independent experiments. * p≤ 0.05 (univariate ANOVA)
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Moreover, DMSO which was used as diluent of the
extracts and fractions unexpectedly showed a virucidal
effect against the particles of rotavirus and astrovirus.
This is an interesting finding since the concentrations of
DMSO that we used were so reduced (lower than
0.016 %); however the antiviral effect exhibited by the
DMSO was significant lower than the activity showed by
the F1 fraction solubilized with this solvent (Fig. 3a
and b). Although the virucidal effect of DMSO was
reported very early [36], this study also reports for the first
time this effect against rotavirus and astrovirus. DMSO is
widely used in the evaluation of biological activity of plant
substances [37–39]. Its low toxicity in cell culture renders
it an excellent solvent for such studies [40]. Additional
studies to elucidate the effect produced by the F1
fraction and DMSO on rotavirus and astrovirus struc-
tures are required.
The last strategy used to evaluate the antiviral activity
of F1 was its addition post-infection, immediately after
the viral adsorption period, measuring the infectious
particles produced after a replicative cycle. Again, the
significant anti-rotavirus and anti-astrovirus activities
were observed with the F1 fraction; however, particularly
on Yuc8, the DMSO treatment showed a stimulation of
the viral yield in comparison with infected cells without
further treatment. A similar effect was reported by
Scholtissek and Muller, where “DMSO by itself had a
certain stimulating effect on virus replication” using
New Castle Virus and Semliki Forest Virus [40]. To date,
only one report has described the post-infection anti-
astrovirus activity of different extracts from 17 medicinal
plants in Nigeria against animal and human viruses in
vitro. The results revealed the inhibitory action of the
cytopathic effect of astrovirus when the extracts were
placed on cells after viral adsorption [41]. However, this
effect was detected at extract concentrations of 1 and
2 mg/ml, which are much higher than those concentra-
tions evaluated in our work.
Conclusions
In conclusion, this study reports for the first time the
antiviral activity exerted by an active fraction obtained
from A. bogotensis on rotavirus and astrovirus infection
in vitro. The results showed suggest another possible nat-
ural alternative to treat rotavirus and astrovirus infections.
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